RFPi

Perfusio is a medical device company based in Greenville, North Carolina. The company employs 11 people and generates $2.5 million in annual revenue. Perfusio develops and markets Certes™, a medical device cleared by the FDA through the 510(k) process as a Class II device. Certes™ utilizes multiple wavelength illumination and AI-enhanced analytics based on laser speckle contrast imaging to display MSPV, or multi-spectral physiologic visualization, of blood flow distribution in tissues. This technology allows surgeons to see blood flow in real-time, without the need for patient contact, dyes, or ionizing radiation. Certes™ provides surgeons with immediate insights into which tissues have normal perfusion and which do not, enabling them to identify and address perfusion problems during surgery. The device's real-time data capture and analysis capabilities enhance surgical decision-making, potentially reducing major complication rates and improving patient outcomes. Additionally, the data collected by Certes™ is stored in the Perfusio-ARMUS Cloud Repository, which facilitates ongoing machine learning and AI analytics for individual patient predictive analytics during surgery. For more information about Perfusio and Certes™, please visit rfpi-co.com.